[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Europa Life Sciences Limited\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100654356","snip-follow-on-case-series-using-v3-device-100654356",false,"NCT07796165","SNIP follow-on Case Series Using v3 Device","SNIP 2 Case Series","Inclusion Criteria:\n\n* Ankyloglossia requiring intervention\n\nExclusion Criteria:\n\n* Concomitant morphological variation in the oral cavity which could compromise frenotomy\n* Blood dyscrasia\n* Immunocompromise","ALL","1 Week","12 Weeks",{"count":20,"type":21},6,"ESTIMATED","INTERVENTIONAL",[24],"NA","Case series of infants with anterior ankyloglossia being treated by the Sublingual Neonatal Incision Platform device",[27],"Ankyloglossia",[29,30,31,32,33],"Infant","Anterior","Posterior","Novel Device","Case Series","NOT_YET_RECRUITING","2026-09-02",{"date":37,"type":38},"2026-09-04","ACTUAL",{"date":40,"type":21},"2026-10-01",{"date":42,"type":21},"2027-01-31",{"name":44,"class":45},"Europa Life Sciences Limited","INDUSTRY",""]